www射-国产免费一级-欧美福利-亚洲成人福利-成人一区在线观看-亚州成人

   

Manufacturers subject to latest drug recall rules

By Shan Juan (China Daily)
Updated: 2007-12-13 07:42

The State Food and Drug Administration (SFA) Wednesday announced a new provision that obliges all manufacturers of imported drugs to provide Chinese authorities with full details of product recalls in a bid to avoid potential health hazards.

The Provisions for Drug Recall, the country's first nationwide regulation on the issue, states that drug manufacturers at home and abroad should be the first to be held accountable for the safety and quality of the drugs they sell, SFDA spokeswoman Yan Jiangying said at its regular monthly press briefing.

The provision states that drugs found to be potentially hazardous should be recalled voluntarily by producers, while those that are found to be fake or of substandard quality will be dealt with under the terms of the Drug Administration Law.

The provision stipulates that recalls are divided into three categories based on different risk levels.

These range from 24 hours for drugs that may cause serious damage to human health, to 72 hours for those deemed non-life-threatening.

Once the hazardous products have been recalled, producers must immediately inform distributors and medical institutions to stop using or selling the drugs.

The manufacturers involved will also have to report the recalls to the drug administration.

"We hope governments and companies can cooperate to enhance and refine the establishment of the recall system to safeguard drug safety and public health," Yan said.

The provision also states that penalties or liabilities for companies that voluntarily recall hazardous drugs will be eased or excused.

Conversely, manufacturers that fail, for whatever reason, to recall hazardous drugs will be subject to compulsory recalls by the authorities if deemed necessary. Such firms will also be fined three times the value of the recalled drugs.

To realize and facilitate adequate drug recalls, producers should also put in place surveillance systems to monitor and look out for potentially harmful products, the SFDA said.

"Drug manufacturers cannot merely rely on government information.

"They should, out of a sense of social responsibility, make efforts to monitor potential adverse reactions to their products," Yan said.

Distributors and medical institutions must also inform the authorities and producers of any safety risks associated with a particular drug, the provision says.

"The involvement of the general public, especially drug distributors and users, is extremely important given the fact that a pilot scheme of drug recalls in Wuhan, capital of Hubei Province, showed that the recalls were imposed in most cases," Yan said.



Top China News  
Today's Top News  
Most Commented/Read Stories in 48 Hours
主站蜘蛛池模板: 精品久久久久中文字幕日本 | ppypp日本欧美一区二区 | 深夜一级毛片 | 成人免费毛片网站 | 成人91在线 | 欧美精品综合一区二区三区 | 中文字幕99在线精品视频免费看 | 久久久国产亚洲精品 | 日韩精品一区二区三区毛片 | 国产免费人视频在线观看免费 | 色综合久久久久久久 | 久久久久久一级毛片免费野外 | 久久99国产一区二区三区 | 欧美成年人视频 | 欧美国产日韩在线 | 日韩1级片| 免费看美女午夜大片 | 久久久视| 国产真实自拍 | 欧美成人乱弄视频 | 日韩经典一区 | 国产中的精品一区的 | 国产黄色在线网站 | 1024色淫免费视频 | 老司机免费福利午夜入口ae58 | 免费观看a黄一级视频 | 免费欧洲毛片a级视频 | 亚洲精品xxx | 91精品国产一区二区三区左线 | 国产精品九九视频 | 国产成人a福利在线观看 | 国产成人a在一区线观看高清 | 国产精品亚洲片夜色在线 | 国产麻豆一级在线观看 | 亚洲视频三区 | 美女福利视频午夜在线 | www.黄色免费网站 | 成人性视频免费网站 | 性视频亚洲| 国产一区二区三区久久小说 | 亚洲精品国产三级在线观看 |